Biopsy

Prostate Biopsy Complications Deter Patients From Re-Biopsy

Prostate Biopsy Complications Deter Patients From Re-Biopsy

By

Study participants with acute urinary retention after TRUS-guided prostate biopsy were 4.5 times more likely to skip a recommended re-biopsy than men who had no initial biopsy-related complications.

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

Negative Confirmatory Biopsy Predicts Lower PCa Progression Risk

By

Men on active surveillance for prostate cancer who had a negative confirmatory biopsy experienced an 88% decreased risk of progression to treatment.

Fosfomycin Tops Fluoroquinolones for Prostate Biopsy Prophylaxis

Fosfomycin Tops Fluoroquinolones for Prostate Biopsy Prophylaxis

By

In a meta-analysis, the risk of infectious complications was 78% lower with fosfomycin trometamol versus fluoroquinolones in men undergoing TRUS-guided prostate biopsy.

Routine Office Urine Culture Before Prostate Biopsy Is Unnecessary

Routine Office Urine Culture Before Prostate Biopsy Is Unnecessary

By

In a single center study, asymptomatic bacteriuria resolved before prostate biopsy, without additional treatment.

Is It Safe to Avoid Biopsy in Men With Elevated PSA?

Is It Safe to Avoid Biopsy in Men With Elevated PSA?

Multiparametric magnetic resonance imaging in conjunction with transrectal ultrasound-guided biopsy improves discrimination between clinically significant and insignificant prostate tumors and can spare patients unnecessary biopsies.

Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications

Repeat Prostate Biopsies Do Not Raise Risk of Post-RP Complications

By

Rates of erectile dysfunction and urinary incontinence at 1, 2, and 3 years after radical surgery are not higher among men who have multiple prostate biopsies while on active surveillance for prostate cancer.

Structured Investigation of Outpatient Transperineal Prostate Biopsy

Structured Investigation of Outpatient Transperineal Prostate Biopsy

The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B.

Less Frequent Biopsies May Be Appropriate for PCa Active Surveillance

Less Frequent Biopsies May Be Appropriate for PCa Active Surveillance

By

Investigators who compared 4 active surveillance cohorts found that biennial prostate biopsies appear to be an acceptable alternative to annual biopsies.

Top Complaint After Prostate Biopsy Is Infection

Top Complaint After Prostate Biopsy Is Infection

Most common infection in prostate biopsy was E. coli, followed by mild bleeding.

Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy

Combined Urinary Testing Helps Detect Aggressive PCa, Avoid Biopsy

Combining testing of urinary T2:ERG, PCA3 at thresholds that detected aggressive prostate cancer improved specificity from 18% to 39%.

Biopsy Timing in Active Surveillance Not Tied to PCa Reclassification

Biopsy Timing in Active Surveillance Not Tied to PCa Reclassification

But PSA density and body mass index are associated with prostate cancer reclassification.

Prostate Biopsy May Be Avoidable if MRI Findings Are Negative

Prostate Biopsy May Be Avoidable if MRI Findings Are Negative

By

In a study, systematic biopsy detected clinically significant prostate cancer in only 3% of men with negative findings on multiparametic MRI.

Prostate MRI Quality May Improve With Bowel Prep

Prostate MRI Quality May Improve With Bowel Prep

By

In multiparametric magnetic resonance imaging, rectal distension have a negative effect on T2-weighted and diffusion-weighted images.

Multiparametric MRI May Prevent Unnecessary Prostate Biopsies

Multiparametric MRI May Prevent Unnecessary Prostate Biopsies

By

Using imaging to triage men with elevated PSA might avoid a quarter of unnecessary biopsies, according to a study.

Office-Based Renal Mass Biopsy Safe

Office-Based Renal Mass Biopsy Safe

By

In a study, only 3 of 108 patients experienced complications, all of which were minor and required no hospitalization or further intervention.

Some AS Patients Eligible for Relaxed Prostate Biopsy Schedules

Some AS Patients Eligible for Relaxed Prostate Biopsy Schedules

Patients on active surveillance with stable disease at the time of initial surveillance prostate biopsy may be appropriate candidates for less intensive surveillance prostate biopsy schedules.

Prostate Cancer AS Patients May Benefit From MRI/Fusion Biopsy

Prostate Cancer AS Patients May Benefit From MRI/Fusion Biopsy

By

In patients undergoing confirmatory biopsy for active surveillance, MRI can increase detection of clinically significant tumors compared with standard systematic biopsy.

<i>PITX2</i> Methylation of Prostate Biopsies Aids Risk Assessment

PITX2 Methylation of Prostate Biopsies Aids Risk Assessment

PITX2 methylation was increased in tumor-positive biopsies.

Prostate Cancer Active Surveillance Criteria May Need Updating

Prostate Cancer Active Surveillance Criteria May Need Updating

By

When MRI-US fusion biopsy is added to the standard 12-core biopsy, the number of men eligible for active surveillance decreases, study finds.

Standard TRUS Prostate Biopsy Needed Despite Negative MRIs

Standard TRUS Prostate Biopsy Needed Despite Negative MRIs

By

Magnetic resonance imaging of the prostate missed 13% of high-grade cancers that were later found on transrectal ultrasound-guided biopsy.

Infections After Prostate Biopsy Continue to Rise

Infections After Prostate Biopsy Continue to Rise

By

Patients are at higher risk with the transrectal rather than transperineal approach.

Fewer Prostate Biopsies After USPSTF Limited PSA Screening

Fewer Prostate Biopsies After USPSTF Limited PSA Screening

Following the 2012 USPSTF recommendation against PSA screening in populations, rates of radical prostatectomy and biopsy have become significantly less common.

Biases Suspected in Prostate Cancer Risk Estimates

Biases Suspected in Prostate Cancer Risk Estimates

Incident prostate cancer cohorts were defined by examining men who were regularly screened from the placebo arms of two large prostate cancer prevention trials.

PCa Deaths Rare Among Men With Benign 1st Biopsy and Low PSA

PCa Deaths Rare Among Men With Benign 1st Biopsy and Low PSA

By

After 20 years, the prostate cancer mortality rate was 0.7% for men with a PSA level of 10 ng/mL or less and benign initial biopsy results.

Urinary Biomarker Index Measures LN Activity Without Biopsy

Urinary Biomarker Index Measures LN Activity Without Biopsy

The development of this scale, once further validated, will give clinicians the ability to verify lupus nephritis activity without the need for an invasive kidney biopsy.

TRUS-biopsy Inferior for Prostate Cancer Detection

TRUS-biopsy Inferior for Prostate Cancer Detection

Transrectal ultrasound-guided (TRUS) prostate biopsy poorly detects and rules out clinically significant prostate cancer.

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

By

In a study, use of the medication was associated with a significant 61% decreased risk.

Prostate Biopsy Rates Fall Following Guideline Updates

Prostate Biopsy Rates Fall Following Guideline Updates

By

The proportion of biopsied men who have complications from the procedure rose from 14% to 18% from 2005 to 2014.

Saturation Prostate Biopsy Not Better

Saturation Prostate Biopsy Not Better

By

Detection of high Gleason grade tumors is not significantly improved versus standard 12-core biopsy.

Renal Mass Biopsy for a Small Renal Mass Can Be Accurate

Renal Mass Biopsy for a Small Renal Mass Can Be Accurate

Between renal mass biopsy, surgical pathology, rate of accuracy in identifying malignancies 97.1%.

Sign Up for Free e-newsletters